297 related articles for article (PubMed ID: 32674059)
1. Myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: a tertiary center experience from Turkey.
Inan B; Gocmen R; Vural A; Colpak AI; Meinl E; Karabudak R; Tuncer A
Mult Scler Relat Disord; 2020 Sep; 44():102376. PubMed ID: 32674059
[TBL] [Abstract][Full Text] [Related]
2. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
5. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder.
Ojha PT; Aglave VB; Soni G; Jagiasi KA; Singh RK; Singh RK; Nagendra S
Neurol India; 2020; 68(5):1106-1114. PubMed ID: 33109860
[TBL] [Abstract][Full Text] [Related]
6. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
[TBL] [Abstract][Full Text] [Related]
9. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.
Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G
Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073
[TBL] [Abstract][Full Text] [Related]
10. Optic neuritis in the era of biomarkers.
Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT
Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702
[TBL] [Abstract][Full Text] [Related]
11. Optic chiasm involvement in AQP-4 antibody-positive NMO and MOG antibody-associated disorder.
Tajfirouz D; Padungkiatsagul T; Beres S; Moss HE; Pittock S; Flanagan E; Kunchok A; Shah S; Bhatti MT; Chen JJ
Mult Scler; 2022 Jan; 28(1):149-153. PubMed ID: 33975499
[TBL] [Abstract][Full Text] [Related]
12. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
[TBL] [Abstract][Full Text] [Related]
13. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review.
Sharma J; Bhatti MT; Danesh-Meyer HV
Clin Exp Ophthalmol; 2021 Mar; 49(2):186-202. PubMed ID: 33426799
[TBL] [Abstract][Full Text] [Related]
15. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
[TBL] [Abstract][Full Text] [Related]
16. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
17. MRI characteristics of MOG-Ab associated disease in adults: An update.
Shor N; Deschamps R; Cobo Calvo A; Maillart E; Zephir H; Ciron J; Papeix C; Durand-Dubief F; Ruet A; Ayrignac X; Cohen M; Deiva K; Laplaud D; Bourre B; Audoin B; Collongues N; Vukusic S; Cotton F; Marignier R;
Rev Neurol (Paris); 2021; 177(1-2):39-50. PubMed ID: 33046261
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
19. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT
Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes.
Ferilli MAN; Valeriani M; Papi C; Papetti L; Ruscitto C; Figà Talamanca L; Ursitti F; Moavero R; Vigevano F; Iorio R
Mult Scler Relat Disord; 2021 May; 50():102837. PubMed ID: 33636614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
